Double-blind, placebo-controlled, randomized clinical trial to compare the effects of Korean ginseng and American ginseng on blood pressure in healthy adults

A Comparative Clinical Trial on the Effects of Korean Ginseng, Korean Red Ginseng, and American Ginseng on the Body Temperature Responses of Koreans Using Through Digital Infrared Thermographic Imaging, Heart Rate Variability, Blood Composition, Cerebral Blood Flow Velocity, and Subjective Symptom Analyses

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0000944

Enrollment

128

Registered

2013-11-29

Start date

2011-01-03

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Korean ginseng, American ginseng, Korean red ginseng group and placebo group use soft capusule with ingredients of 4-year-old Korean ginseng powder 400 mg, 4-year-old American ginseng powder 40

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Men and women aged 20 to 49 2. Capable of deciding to participate in this clinical trial and of signing the subject consent or having a guardian sign 3. Can be tracked and observed during the clinical trial 4. Meet the washout conditions and agree to comply with the restrictive conditions during the clinical trial. 5. In the case of those who have ingested health food products that contain ginseng properties, including ginseng and red ginseng, those who agree to participate in the restrictive conditions after undergoing a seven-day washout period.

Exclusion criteria

Exclusion criteria: 1. Current use of prescription medication (e.g. hypoglycemic, antihypertensive, hyperlipidemic, antithyroidal, menopausal, steroid hormone, or herbal drugs) 2. Diagnosis of cardiovascular, endocrine, or immune disease within the last three months 3. Pregnancy, breast-feeding, or intent to become pregnant during the trial 4. serious medical or psychiatric condition making participation in the trial unsuitable 5. current use of a ginseng-containing product or having used a ginseng product within the last three months

Design outcomes

Primary

Measure	Time frame
Blood pressure	—

Secondary

Measure	Time frame
Vital signs;Blood composition;Adverse events	—

Countries

Korea, Republic of

Contacts

Public ContactMin Ah Kwak

Daegu Oriental Hospital of Daegu Haany University

nari003@hanmail.net

Outcome results